352451 <common-name>2-[4-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-oxo-5-[(z)-n,n,n'-tris[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]pyrimidin-1-yl]acetic acid</common-name> <description>2-[4-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-oxo-5-[(z)-n,n,n'-tris[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]pyrimidin-1-yl]acetic acid is a chemical compound with the formula C32H49N5O13. With an average molecular weight of 711.80 g/mol, 2-[4-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-oxo-5-[(z)-n,n,n'-tris[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]pyrimidin-1-yl]acetic acid is a heavy molecule.</description> <cas>1631157-62-4</cas> <pubchem-id>155164342</pubchem-id> <chemical-formula>C32H49N5O13</chemical-formula> <weight>711.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:47:40Z</created-at> <updated-at type="dateTime">2026-08-31T18:47:40Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)(C)OC(=O)N=C(C1=CN(C(=O)N=C1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)CC(=O)O)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C</moldb-smiles> <moldb-formula>C32H49N5O13</moldb-formula> <moldb-inchi>InChI=1S/C32H49N5O13/c1-28(2,3)46-23(41)34-21(37(26(44)49-31(10,11)12)27(45)50-32(13,14)15)18-16-35(17-19(38)39)22(40)33-20(18)36(24(42)47-29(4,5)6)25(43)48-30(7,8)9/h16H,17H2,1-15H3,(H,38,39)/b34-21-</moldb-inchi> <moldb-inchikey>HJQHDGKKRVXYMH-ZXSNDDASSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">711.3326866</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM348344</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[4-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-2-oxo-5-[(z)-n,n,n'-tris[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]pyrimidin-1-yl]acetic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0302739</sync-id> <structure-inchikey>HJQHDGKKRVXYMH-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000080000000200000000000000000000000000001000040100000000000102000000000000000200480400000002000000080000000000000000000400000000000000000000000402000000000010000000400000000000000000001100000000000000000400000080000010a000000000000000000000000000040000000000200000000000000000000000000000000000000010000200000008000000000000000080000800000000000010000000000000000004000000000020000040000001000000000000000000000000000400000000000000000008001000101100040010008400400000000000000000100000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAyAAAAMgAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAQMGAGAAAAABAwgAKAAAAAMCBgAoAAAAAwQIACgAAAADAgcAKAAA AAMDBgAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQI ACgAAAADAgdAKAAAAAMDBkAoAAAAAwQHACgAAAADAwYAKAAAAAMECAAoAAAA AwIIACgAAAADAgYAIAAAAAQGAGAAAAABAwYAYAAAAAEDBgBgAAAAAQMGACgA AAADBAgAKAAAAAMCCAAoAAAAAwIGACAAAAAEBgBgAAAAAQMGAGAAAAABAwYA YAAAAAEDBgBgAAAAAgIGACgAAAADBAgAKAAAAAMCCABoAAAAAwEBBwAoAAAA AwMGACgAAAADBAgAKAAAAAMCCAAoAAAAAwIGACAAAAAEBgBgAAAAAQMGAGAA AAABAwYAYAAAAAEDBgAoAAAAAwQIACgAAAADAggAKAAAAAMCBgAgAAAABAYA YAAAAAEDBgBgAAAAAQMGAGAAAAABAwsAAQABAgABAwABBAAEBSAFBigCBQcg BwgoAggJIAkKaAwKC2gMCwxoDAwNKAIMDmgMDg9oDA8QIBARIBESKAIREyAT FAAUFQAUFgAUFwAQGCAYGSgCGBogGhsAGxwAGx0AGx4ACx8AHyAAICEoAiAi IAgjICMkICQlKAIkJiAmJwAnKAAnKQAnKgAjKyArLCgCKy0gLS4ALi8ALjAA LjEADwloDEIBAAAABgkPDgwLChcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:50:13Z</structure-indexed-at> </compound>